203 related articles for article (PubMed ID: 14582700)
41. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
42. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue.
Monks NR; Blakey DC; Curtin NJ; East SJ; Heuze A; Newell DR
Br J Cancer; 2001 Sep; 85(5):764-71. PubMed ID: 11531265
[TBL] [Abstract][Full Text] [Related]
43. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
44. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivo.
Jagetia GC; Baliga MS
Phytother Res; 2006 Feb; 20(2):103-9. PubMed ID: 16444661
[TBL] [Abstract][Full Text] [Related]
46. A comparative study on cytogenetic and antineoplastic effects induced by two modified steroidal alkylating agents.
Papageorgiou A; Tsavdaridis D; Geromichalos GD; Camoutsis C; Karaberis E; Mourelatos D; Chrysogelou E; Houvartas S; Kotsis A
Cancer Detect Prev; 2001; 25(4):369-74. PubMed ID: 11531014
[TBL] [Abstract][Full Text] [Related]
47. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
Sanyal U; Dutta S; Das H
Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
[TBL] [Abstract][Full Text] [Related]
49. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological activity of mustard derivatives of thymine.
Hadj-Bouazza A; Teste K; Colombeau L; Chaleix V; Zerrouki R; Kraemer M; Sainte Catherine O
Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):439-48. PubMed ID: 18569783
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
52. Modulation of the cellular toxicity of nitrogen mustard in murine cells.
Ritter C; Rutman RJ; Goldstein NO
Cancer Res; 1987 Jan; 47(2):472-6. PubMed ID: 3791235
[TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
Lacroix J; Gaudreault RC; Pagé M; Joly LP
Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
[TBL] [Abstract][Full Text] [Related]
54. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
55. A new substance effective against transplantable tumors in vivo: L-cystine-bis-(N,N-beta-chloroethyl)-hydrazide.
Golovinsky EV; Alexiev BV; Spassov AV; Stoev SB; Emanuilov EA; Angelov II; Maneva LS; Stoychev TS
Neoplasma; 1977; 24(4):401-4. PubMed ID: 904741
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A.
Wang Y; Wright SC; Larrick JW
Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status.
Rachid Z; Brahimi F; Domarkas J; Jean-Claude BJ
Bioorg Med Chem Lett; 2005 Feb; 15(4):1135-8. PubMed ID: 15686928
[TBL] [Abstract][Full Text] [Related]
58. Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation.
Bacherikov VA; Chou TC; Dong HJ; Chen CH; Lin YW; Tsai TJ; Su TL
Bioorg Med Chem Lett; 2004 Sep; 14(18):4719-22. PubMed ID: 15324894
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
Bhattacharya S; Ganguly C; Sanyal U; Das S
Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193
[TBL] [Abstract][Full Text] [Related]
60. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
